PubRank
Search
About
Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer
Clinical Trial ID NCT00836407
PubWeight™ 12.74
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT00836407
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer.
J Immunother
2013
2.80
2
Potential targets for pancreatic cancer immunotherapeutics.
Immunotherapy
2011
1.29
3
CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases.
Cancer Immunol Immunother
2011
1.10
4
Therapeutic cancer vaccines: past, present, and future.
Adv Cancer Res
2013
0.99
5
Trial Watch: Immunostimulatory cytokines.
Oncoimmunology
2013
0.96
6
Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander".
Toxins (Basel)
2014
0.92
7
IP-10/CXCL10 attracts regulatory T cells: Implication for pancreatic cancer.
Oncoimmunology
2015
0.87
8
Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma.
Expert Opin Pharmacother
2011
0.80
9
Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival.
Int J Cancer
2014
0.80
10
Modulation of CTLA-4 and GITR for cancer immunotherapy.
Curr Top Microbiol Immunol
2011
0.80
11
Application of radiation technology in vaccines development.
Clin Exp Vaccine Res
2015
0.78
12
Next-generation cancer vaccine approaches: integrating lessons learned from current successes with promising biotechnologic advances.
J Natl Compr Canc Netw
2013
0.77
Next 100